Thomas Jerussi
54Patents
12h-index
17Co-inventors
81Inventor score
Filing activity: Aug 13, 1986 → May 10, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6342496B1 | Bupropion metabolites and methods of use | Chemistry; Metallurgy | 146 | Expired |
| US6489341B1 | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives | Human Necessities | 29 | Expired |
| US5739151A | Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride | Human Necessities | 25 | Expired |
| US5807541A | NSAID/fluoride periodontal compositions and methods | Human Necessities | 21 | Expired |
| US6476078B2 | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction | Human Necessities | 20 | Expired |
| US6303145A | (S,R) formoterol methods and compositions | Human Necessities | 20 | Expired |
| US7189715B2 | Compositions comprising zopiclone derivatives and methods of making and using the same | Chemistry; Metallurgy | 17 | Expired |
| US7087785B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide | Chemistry; Metallurgy | 15 | Expired |
| US6632827B2 | Compositions of optically pure (+) norcisapride | Human Necessities | 14 | Expired |
| US6197828A | Derivatives of (+)-venlafaxine and methods of preparing and using the same | Human Necessities | 13 | Expired |
| US6294582A | Methods for treatment of asthma using S-oxybutynin | Human Necessities | 13 | Expired |
| US7105699B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide | Chemistry; Metallurgy | 13 | Expired |
| US7790772B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine | Chemistry; Metallurgy | 11 | Active |
| US5877188A | Methods for treating central nervous system disorders using optically pure (+) norcisapride | Human Necessities | 11 | Expired |
| US7589237B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine | Chemistry; Metallurgy | 11 | Active |
| US7423179B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine | Chemistry; Metallurgy | 10 | Expired |
| US6114356A | Method for treating gastrointestinal disorders using (+) norcisapride | Human Necessities | 10 | Expired |
| US6780891B2 | Tramadol analogs and uses thereof | Chemistry; Metallurgy | 9 | Expired |
| US6339086B1 | Methods of making and using N-desmethylzopiclone | Chemistry; Metallurgy | 7 | Expired |
| US8134029B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine | Chemistry; Metallurgy | 7 | Active |
| US6242465A | Compositions of optically pure (+) norcisapride | Human Necessities | 7 | Expired |
| US6331571A | Methods of treating and preventing attention deficit disorders | Human Necessities | 6 | Expired |
| US6342533B1 | Derivatives of (−)-venlafaxine and methods of preparing and using the same | Chemistry; Metallurgy | 6 | Expired |
| US7456173B2 | Compositions comprising zopiclone derivatives and methods of making and using the same | Chemistry; Metallurgy | 6 | Active |
| US6147093A | Methods for treating gastroesophageal reflux disease | Human Necessities | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.